RecruitingNCT06610669

The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry

The Prevalence, Patients' Characteristics, and Hyper-Lp(a)-Emia Risk Factors in the Polish Population. The Polish Mother's Memorial Hospital Research Institute Lipoprotein(a) Registry

Sponsor

Polish Mother Memorial Hospital Research Institute

Enrollment

2,000 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

Lipoprotein(a), Hyper-Lp(a)-Emia

Summary

The PMMHRI-Lp(a)-Registry is a non-interventional, single-center registry conducted in the Polish Mother's Memorial Hospital Research Institute (PMMHRI). The PMMHRI-Lp(a)-Registry was established in January 2022. Since then, all consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration have been included.

Eligibility

Inclusion Criteria1

measured lipoprotein(a) concentration

Exclusion Criteria1

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Polish Mother Memorial Research Institute

Lodz, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06610669